Different chromogranin immunoreactivity between prion and a-beta amyloid plaque

NeuroReport

Volumn 14, Issue 5, 2003, Pages 755-758

  Rangon, Claire Marie ^a   Haïk, Stéphane ^a   Faucheux, Baptiste A ^a   Metz Boutigue, Marie Helène ^b   Fierville, Françoise ^a   Fuchs, Jean Paul ^b   Hauw, Jean Jacques ^a   Aunis, Dominique ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

A ; Alzheimer's disease; Amyloid; Chromogranins; Creutzfeldt Jakob disease; Microglia; Neurodegeneration; Prion protein

Indexed keywords

AMYLOID BETA PROTEIN; CHROMOGRANIN; CHROMOGRANIN A; CHROMOGRANIN B; PRION PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KURU; MALE; MICROGLIA; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CEREBELLUM; CHROMOGRANIN A; CHROMOGRANINS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEURITES; PRIONS; SENILE PLAQUES; TEMPORAL LOBE;

EID: 0037728592     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200304150-00019     Document Type: Article

References (25)

1. Chiesa R and Harris DA. Neurobiol Dis 8, 743-763 (2001).
2. Simon JP and Aunis D. Biochem J 262, 1-13 (1989).
3. Winkler H and Fischer-Colbrie R. Neuroscience 49, 497-528 (1992).
4. Nishimura M, Tomimoto H, Suenaga T et al. Brain Res 634, 339-344 (1994).
5. Yasuhara O, Kawamata T, Aimi Y et al. Neurosci Lett 171, 73-76 (1994).
6. Munoz DG. Lab Invest 64, 826-832 (1991).
7. Brion JP, Couck AM, Bruce M et al. Brain Res 539, 143-150 (1991).
8. Taupenot L, Ciesielski-Treska J, Ulrich G et al. Neuroscience 72, 377-389 (1996).
9. Ciesielski-Treska J, Ulrich G, Taupenot L et al. J Biol Chem 273, 14339-14346 (1998).
10. Ciesielski-Treska J, Ulrich G, Chasserot-Golaz S et al. J Biol Chem 276, 13113-13120 (2001).
11. Guiroy DC, Wakayama I, Liberski PP and Gajdusek DC. Acta Neuropathol 87, 526-530 (1994).
12. Muhleisen H, Gehrmann J and Meyermann R. Neuropathol Appl Neurobiol 21, 505-517 (1995).
13. Hauw JJ, Sazdovitch V, Laplanche JL et al. Neurology 54, 1641-1646 (2000).
14. Taupenot L, Remacle JE, Helle KB et al. Regulat Pept 56, 71-88 (1995).
15. Kimurat N, Pilichowska M, Okamoto H et al. Mod Pathol 13, 140-146 (2000).
16. Williams A, Lucassen PJ, Ritchie D and Bruce M. Exp Neurol 144, 433-438 (1997).
17. Brown DR, Schmidt B and Kretzschmar HA. Nature 380, 345-347 (1996).
18. Giese A, Brown DR, Groschup MH et al. Brain Pathol 8, 449-457 (1998).
19. Peyrin J, Lasmezas C, Haik S et al. Neuroreport 10, 723-729 (1999).
20. Doh-ura K, Perryman S, Race R and Chesebro B. Microb Pathog 18, 1-9 (1995).
21. Aunis D. Int Rev Cytol 181, 213-320 (1998).
22. Kingham PJ, Cuzner ML and Pocock JM. J Neurochem 73, 538-547 (1999).
23. Kingham PJ and Pocock JM. J Neurochem 76, 1475-1484 (2001).
24. Lassmann H, Weiler R, Fischer P et al. Neuroscience 46, 1-8 (1992).
25. Wang D and Munoz DG. J Neuropathol Exp Neurol 54, 548-556 (1995).